Benzinga's Top Initiations

Analysts at Stephens & Co. initiated coverage on

with a Equal-weight rating. The target price for Tribune Media is set to $42. Tribune Media shares closed at $36.19 on Tuesday. Analysts at Goldman Sachs initiated coverage of

with a Buy rating. The target price for BioMarin Pharmaceutical is set to $158. BioMarin Pharmaceutical shares closed at $107.32 on Tuesday. Piper Jaffray initiated coverage of

with a Overweight rating. The target price for Align Technology is set to $74. Align Technology shares closed at $65.28 on Tuesday. Analysts at Bank of America initiated coverage on

with a Buy rating. The target price for Allegion is set to $75. Allegion shares closed at $64.59 on Tuesday. JP Morgan initiated coverage on

with a Neutral rating. The target price for Fulton Financial is set to $14.50. Fulton Financial shares closed at $14.08 on Tuesday. Stephens & Co. initiated coverage on

with a Equal-weight rating. The target price for Meredith is set to $50. Meredith shares closed at $45.67 on Tuesday. Goldman Sachs initiated coverage on

with a Neutral rating. The target price for ISIS Pharmaceuticals is set to $65. ISIS Pharmaceuticals shares closed at $61.32 on Tuesday. Analysts at Citigroup initiated initiated coverage on

with a Buy rating. The target price for Halozyme Therapeutics is set to $25. Halozyme Therapeutics shares closed at $15.64 on Tuesday. Analysts at Wunderlich initiated coverage on

with a Buy rating. The target price for Inventure Foods is set to $13. Inventure Foods shares closed at $6.92 on Tuesday. Analysts at BB&T Capital initiated coverage on

with a Buy rating. The target price for OSI Systems is set to $103. OSI Systems shares closed at $85.34 on Tuesday.